Andreas Hadjimichael, 10% Owner at Acrivon Therapeutics, Inc. (ACRV), bought 410,657 shares at $12.50 ($5.0M) on 2022-11-17, disclosed to the SEC on 2022-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 10,657 | $0 | 0.0% |
| 2 | $12.50 | 400,000 | $5.0M | 100.0% |
| Total | $12.18 avg | 410,657 | $5.0M | 100% |
| Filing → |
| KPTI | SELL | 2016-06-27 | $302K | — | Filing → |
| KPTI | SELL | 2016-05-23 | $298K | — | Filing → |
| KPTI | SELL | 2016-05-12 | $362K | — | Filing → |